Trust Point Inc. Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Trust Point Inc. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,409 shares of the healthcare conglomerate’s stock after buying an additional 194 shares during the quarter. Trust Point Inc.’s holdings in UnitedHealth Group were worth $2,578,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Buckingham Capital Management Inc. grew its position in shares of UnitedHealth Group by 1.4% in the first quarter. Buckingham Capital Management Inc. now owns 25,283 shares of the healthcare conglomerate’s stock valued at $12,508,000 after purchasing an additional 337 shares in the last quarter. Triangle Securities Wealth Management boosted its position in shares of UnitedHealth Group by 1.7% in the first quarter. Triangle Securities Wealth Management now owns 4,177 shares of the healthcare conglomerate’s stock valued at $2,066,000 after acquiring an additional 70 shares during the period. Johnson & White Wealth Management LLC increased its holdings in UnitedHealth Group by 4.9% during the 1st quarter. Johnson & White Wealth Management LLC now owns 1,532 shares of the healthcare conglomerate’s stock worth $758,000 after acquiring an additional 71 shares during the period. BTC Capital Management Inc. bought a new position in UnitedHealth Group in the 1st quarter valued at $7,827,000. Finally, Cardano Risk Management B.V. increased its holdings in shares of UnitedHealth Group by 4.0% in the first quarter. Cardano Risk Management B.V. now owns 200,595 shares of the healthcare conglomerate’s stock worth $99,234,000 after purchasing an additional 7,626 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $569.61 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The firm has a 50-day moving average of $584.42 and a 200 day moving average of $533.63. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The company has a market cap of $525.99 billion, a P/E ratio of 37.77, a PEG ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the firm earned $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s payout ratio is currently 55.70%.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent analyst reports. Stephens reduced their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday. Robert W. Baird raised their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. Barclays upped their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $615.58.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.